Funds are grouped in the top three, with open interest driving the market.

#1 $INX +58.1%
Fee rate 0.073, OI+312.1%.
成交$172M，taker 1.04.
The squeeze is the strongest, sentiment is very hot.
#2 $BILL +41.5%
Fee rate 0.041, OI+141.5%.
成交$531M, long-short ratio 1.37.
Not a fake pull, volume and positions are both online.
#3 $Q +33.6%
Fee rate 0.005, OI+56.9%.
成交$66M, taker 1.08.
Chasing gains isn't that crowded, but positions are flowing in.
#4 $PTB +29.6%
Depth not provided, trading volume not disclosed.
Leading in gains, like pure beta diffusion.
#5 $SAHARA +28.2%
Depth not provided, OI not disclosed.
Following the strong trend, watch volume on the order book.
#6 $ZEREBRO +24.7%
Depth not provided, fee rate not disclosed.
Popularity remains, but structure isn't as clear as the top three.
#7 $BAS +23.3%
Depth not provided, trading volume not disclosed.
Belongs to the late-stage rally group, still has room for flexibility.
#8 $MITO +23.1%
Depth not provided, OI not disclosed.
Gains are close to BAS, sentiment is spreading in sync.
#9 $BIO +22.8%
Depth not provided, fee rate not disclosed.
There is heat, but contract confirmation is lacking.
#10 $LAB +18.9%
Depth not provided, trading volume not disclosed.
Still strong at the tail end, indicating beta hasn't dispersed.
Top 4-10:
PTB +29.6%, SAHARA +28.2%,
ZEREBRO +24.7%, BAS +23.3%,
MITO +23.1%, BIO +22.8%,
LAB +18.9%.
Short squeeze candidates:
INX, BILL, Q all show a surge in open interest.
INX is the most extreme, the longer it drags, the easier it is to trigger a move.
Overall, it's a market of stronger contracts getting stronger,
Focusing on the continuation of INX and BILL.
Generated using Claude Opus 4.7 model.
Claude is AI and may make mistakes.
Please double-check responses.